- Scrip Originals
Brought to you by
IPO on London exchange nets £18.2mm for Neuropharm Group
06 Mar 2007
Start-up CNS drug developer Neuropharm Group PLC netted £18.2mm ($35.4mm) in its initial public offering of 15.7mm ordinary shares at £1.27 each on the London Stock Exchange's AIM.
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com